CH M2
EWG), is an interface for the pharmaceutical industry to agency transfer of
regulatory information. The content is based on the Common Technical
Document (CTD) format.
For more information about Intrasphere's PharmaCM Submissions
Management and Authoring module, contact us at (212) 937-8200.
About Intrasphere Technologies
Intrasphere Technologies, Inc. (http://www.intrasphere.com) is a consulting
firm focused on the Life Sciences industry. We provide comprehensive,
business-focused services that help companies achieve meaningful results.
Some of the world's leading global companies including Pfizer Inc.,
Johnson & Johnson, Novartis, Eli Lilly and Vertex Pharmaceuticals, among
others, look to Intrasphere as their trusted solutions partner.
Founded in 1996, Intrasphere is headquartered in New York City with
operations in Europe and Asia. Intrasphere has been recognized nationally
for performance by industry leading organizations such as, Deloitte &
Touche, Crain's New York Business and Inc. Magazine.
'/>"/>SOURCE Intrasphere Technologies Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Neurobiological Technologies Sets Date for Second Quarter Financial Results2.
Emisphere Technologies to Present at BIO CEO & Investor Conference on February 123.
Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)4.
Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"5.
Genelabs Technologies, Inc. Announces Resignation of President and CEO6.
Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market7.
Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic8.
Neptune Technologies receives GRAS notification in the United States9.
VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 710.
Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair11.
Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA